Two new drugs, the first capable of slowing down the debilitating progression of Alzheimer's disease, have become embroiled ...

In the past two years, the U.S. Food and Drug Administration has approved two monoclonal antibody treatments to slow ...

Researches have helped in detecting the disease in early stages and drugs are now being made available for an effective and ...

On World Alzheimer’s Day, we examine how a timely diagnosis can prepare someone with early dementia, and the pros and cons of ...

Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk ...

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

Much of the brain is made up of a constellation of star-shaped cells called astrocytes, which play vital roles in immunity, ...

Bre Teamer chats with Dr. Alex Zayid of Icon Anti-Aging about recent developments and research that supports using ...

(WWSB) - 35 years ago, a pair of scientists made a discovery that they believed would change Alzheimer’s research forever.

The FDA’s approval of Kisunla demonstrates a positive change in Alzheimer disease management. Offering illness pathology therapy and the option of treatment conclusion after reaching therapeutic goals ...

Analyst Jason McCarthy from Maxim Group maintained a Buy rating on Inmune Bio (INMB – Research Report) and keeping the price target at ...

New research suggests that the lessening of amyloid-beta in the brain is behind cognitive decline in Alzheimer's and boosting ...